1772P Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform.
Saved in:
| Title: | 1772P Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform. |
|---|---|
| Authors: | Crabb, S.J.1 (AUTHOR), Dempsey, L.2 (AUTHOR), Soulis, E.2 (AUTHOR), Hinsley, S.2 (AUTHOR), Song, Y.P.3 (AUTHOR), Barber, J.4 (AUTHOR), Frew, J.5 (AUTHOR), Gale, J.6 (AUTHOR), Faust, G.7 (AUTHOR), Brock, S.8 (AUTHOR), McGovern, U.B.9 (AUTHOR), Parikh, O.A.10 (AUTHOR), Enting, D.11 (AUTHOR), Sundar, S.12 (AUTHOR), Ratnayake, G.13 (AUTHOR), Lees, K.14 (AUTHOR), Hussain, S.A.15 (AUTHOR), Powles, T.B.16 (AUTHOR), Jones, R.2 (AUTHOR), Tapper, W.17 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1348-S1348. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.07.1850 |
